AU3025599A - Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition - Google Patents

Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition

Info

Publication number
AU3025599A
AU3025599A AU30255/99A AU3025599A AU3025599A AU 3025599 A AU3025599 A AU 3025599A AU 30255/99 A AU30255/99 A AU 30255/99A AU 3025599 A AU3025599 A AU 3025599A AU 3025599 A AU3025599 A AU 3025599A
Authority
AU
Australia
Prior art keywords
composition
cancer
preparation
treatment
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30255/99A
Inventor
Even Marstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3025599A publication Critical patent/AU3025599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU30255/99A 1998-04-07 1999-03-30 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition Abandoned AU3025599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK499/98 1998-04-07
DK199800499A DK173459B1 (en) 1998-04-07 1998-04-07 Preparation for the treatment of cancer and ulcerative colitis and the use of a titanium complex and a zinc salt for the preparation of
PCT/DK1999/000187 WO1999051585A1 (en) 1998-04-07 1999-03-30 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition

Publications (1)

Publication Number Publication Date
AU3025599A true AU3025599A (en) 1999-10-25

Family

ID=8094264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30255/99A Abandoned AU3025599A (en) 1998-04-07 1999-03-30 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition

Country Status (4)

Country Link
EP (1) EP1086090A1 (en)
AU (1) AU3025599A (en)
DK (1) DK173459B1 (en)
WO (1) WO1999051585A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005020327A1 (en) 2005-04-30 2006-11-09 Multibind Biotec Gmbh Decontamination solutions and their use for denaturation, modification, degradation, solubilization and removal of proteins, nucleic acid molecules and microorganisms from surfaces
DE102006001213A1 (en) * 2006-01-10 2007-07-12 Multibind Biotec Gmbh Synergistic solution of ascorbic acid or its derivatives and metal ions efficient, selective killing of pathological mammalian cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211712A (en) * 1977-01-17 1980-07-08 Even Marstrand Complex compound for the treatment of diseases disclosing abnormal blood pictures
US5234698A (en) * 1988-07-05 1993-08-10 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
US5639787A (en) * 1995-02-28 1997-06-17 The Center For The Improvement Of Human Functioning Int'l, Inc. Therapeutic method for the treatment of cancer

Also Published As

Publication number Publication date
EP1086090A1 (en) 2001-03-28
WO1999051585A1 (en) 1999-10-14
DK173459B1 (en) 2000-11-27

Similar Documents

Publication Publication Date Title
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU1920900A (en) Solid water treatment composition and methods of preparation and use
AU2212299A (en) Compositions and methods for the treatment of tumor
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU1941301A (en) Implantable nickel-free stainless steel stents
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU5032500A (en) Treatment of irregular ventricular contractions
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
AU2039800A (en) 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
AU2339699A (en) Aqueous metal treatment composition
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AU5845099A (en) Use of (pex) in the treatment of metabolic bone diseases
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5487699A (en) Adhesive compositions for the hard tissues of the human body
AU2998900A (en) Zinc chloride in treating skin diseases
AU5759000A (en) Cold-plasma deposition treatment of seeds and other living matter
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3025599A (en) Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition
AU1878201A (en) Composition for the treatment of damaged tissue
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU6331099A (en) Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
GB9912167D0 (en) Antiperspirant salts and methods of their preparation
AU5552400A (en) Treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase